Overview

Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if cidofovir gel (Forvade) is safe and effective in treating herpes simplex in patients with AIDS who do not respond to acyclovir.
Phase:
N/A
Details
Lead Sponsor:
Gilead Sciences
Treatments:
Acyclovir
Cidofovir